๐ต๏ธ Jasper Therapeutics, Inc. ($JSPRW)
SEC insider & ownership activity, last 12 months ยท CIK 1788028 ยท every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Jun 3, 2026.
Insider flow
4 buyers, value withheld pending verification (4 lots) ยท 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Thomas G. Wiggans | 1 | value withheld pending verification | 0 | โ | Sep 22, 2025 |
| Lucas Svetlana | 1 | value withheld pending verification | 0 | โ | Sep 22, 2025 |
| Martell Ron | 1 | value withheld pending verification | 0 | โ | Sep 22, 2025 |
| Shizuru Judith Anne | 1 | value withheld pending verification | 0 | โ | Sep 22, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Soleus GP LLC | 10.0% | 13G | Feb 11, 2025 | filing โ | |
| Velan Capital Investment Management LP | 9.9% | 13G | Aug 17, 2026 | filing โ | |
| Velan Capital Management LLC | 9.9% | 13G | Aug 17, 2026 | filing โ | |
| Morgan Adam | 9.9% | 13G | Aug 17, 2026 | filing โ | |
| Venkataraman Balaji | 9.9% | 13G | Aug 17, 2026 | filing โ | |
| Velan Capital Investment Management LP | 9.9% | 13D | Jul 16, 2026 | filing โ | |
| Velan Capital Management LLC | 9.9% | 13D | Jul 16, 2026 | filing โ | |
| Morgan Adam | 9.9% | 13D | Jul 16, 2026 | filing โ | |
| Venkataraman Balaji | 9.9% | 13D | Jul 16, 2026 | filing โ | |
| Velan Capital Master Fund LP | 8.9% | 13G | Aug 17, 2026 | filing โ | |
| Velan Capital Holdings LLC | 8.9% | 13G | Aug 17, 2026 | filing โ | |
| Velan Capital Master Fund LP | 8.9% | 13D | Jul 16, 2026 | filing โ | |
| Velan Capital Holdings LLC | 8.9% | 13D | Jul 16, 2026 | filing โ | |
| T. ROWE Price Investment Management, Inc. | 7.1% | 13G | Nov 14, 2025 | filing โ | |
| Anders Hove | 5.3% | 13G | Jan 26, 2026 | filing โ | |
| Kingdon Capital Management, L.L.C. | 5.1% | 13G | Jul 11, 2025 | filing โ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Aug 21, 2026 | filing โ |
| Earnings (2.02) | Aug 14, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2026 | filing โ |
| Shareholder vote (5.07) | Jul 31, 2026 | filing โ |
| Other events (8.01) | Jul 31, 2026 | filing โ |
| Material agreement (1.01) | Jul 16, 2026 | filing โ |
| Acquisition or disposition (2.01) | Jul 16, 2026 | filing โ |
| Unregistered equity sale (3.02) | Jul 16, 2026 | filing โ |
| Officer/director changes (5.02) | Jul 16, 2026 | filing โ |
| Charter/bylaw changes (5.03) | Jul 16, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jul 16, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jul 16, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing โ |
| Delisting notice (3.01) | Jun 3, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jun 1, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing โ |
| Officer/director changes (5.02) | May 15, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing โ |
| Earnings (2.02) | May 14, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing โ |
| Earnings (2.02) | Mar 30, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing โ |
| Other events (8.01) | Jan 8, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing โ |
| Officer/director changes (5.02) | Jan 2, 2026 | filing โ |
| Other events (8.01) | Jan 2, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jan 2, 2026 | filing โ |
| Other events (8.01) | Dec 2, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Dec 2, 2025 | filing โ |